Moderna, Inc.
MRNA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $15,967 | $37,990 | $70,770 | $102,354 |
| - Cash | $1,927 | $2,907 | $3,205 | $6,848 |
| + Debt | $747 | $1,243 | $1,200 | $916 |
| Enterprise Value | $14,787 | $36,326 | $68,765 | $96,422 |
| Revenue | $3,199 | $6,848 | $18,875 | $17,736 |
| % Growth | -53.3% | -63.7% | 6.4% | – |
| Gross Profit | $1,735 | $2,155 | $13,459 | $15,119 |
| % Margin | 54.2% | 31.5% | 71.3% | 85.2% |
| EBITDA | -$3,394 | -$3,283 | $9,768 | $13,528 |
| % Margin | -106.1% | -47.9% | 51.8% | 76.3% |
| Net Income | -$3,561 | -$4,714 | $8,362 | $12,202 |
| % Margin | -111.3% | -68.8% | 44.3% | 68.8% |
| EPS Diluted | -9.27 | -12.34 | 20.1 | 28.29 |
| % Growth | 24.9% | -161.4% | -29% | – |
| Operating Cash Flow | -$3,004 | -$3,118 | $4,981 | $13,620 |
| Capital Expenditures | -$1,051 | -$707 | -$400 | -$284 |
| Free Cash Flow | -$4,055 | -$3,825 | $4,581 | $13,336 |